The immune signatures of multiple sclerosis: Lessons from twin studies.

Tytuł:: The immune signatures of multiple sclerosis: Lessons from twin studies.
Autorzy:: Villoslada P; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305; .
Zamvil SS; Department of Neurology, University of California, San Francisco, CA 94143.
Źródło:: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Sep 29; Vol. 117 (39), pp. 24013-24015. Date of Electronic Publication: 2020 Sep 14.
Typ publikacji:: Journal Article; Comment
Język:: English
Imprint Name(s):: Original Publication: Washington, DC : National Academy of Sciences
MeSH Terms:: Multiple Sclerosis*/genetics
Twins, Monozygotic*
Humans ; Twins, Dizygotic
References:: Nat Rev Neurol. 2015 Mar;11(3):134-42. (PMID: 25686758)
Nat Rev Neurol. 2017 Jan;13(1):25-36. (PMID: 27934854)
AJNR Am J Neuroradiol. 2020 Sep;41(9):1542-1549. (PMID: 32763896)
Nat Rev Immunol. 2015 Sep 15;15(9):545-58. (PMID: 26250739)
J Clin Invest. 2019 Nov 1;129(11):4758-4768. (PMID: 31566584)
Nat Immunol. 2018 Mar;19(3):302-314. (PMID: 29476184)
Curr Opin Immunol. 2019 Dec;61:46-53. (PMID: 31476445)
Sci Transl Med. 2018 Oct 10;10(462):. (PMID: 30305453)
Sci Transl Med. 2018 Oct 10;10(462):. (PMID: 30305455)
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21546-21556. (PMID: 32817525)
Lancet Neurol. 2016 Mar;15(3):317-31. (PMID: 26724102)
BMC Syst Biol. 2014 Nov 11;8:120. (PMID: 25385554)
Ann Neurol. 2012 Oct;72(4):610-24. (PMID: 23109155)
Science. 2001 Jul 13;293(5528):240-5. (PMID: 11452112)
PLoS Comput Biol. 2017 Oct 26;13(10):e1005757. (PMID: 29073203)
Mult Scler. 2020 Mar 31;:1352458520914844. (PMID: 32228281)
Cell. 2018 Sep 20;175(1):85-100.e23. (PMID: 30173916)
Lancet Neurol. 2016 Feb;15(2):198-209. (PMID: 26724103)
Neurol Neuroimmunol Neuroinflamm. 2020 Mar 5;7(3):. (PMID: 32139439)
Nat Biotechnol. 2014 Feb;32(2):149-57. (PMID: 24441473)
Ann Neurol. 2018 Jan;83(1):13-26. (PMID: 29244240)
J Exp Med. 2005 Aug 15;202(4):473-7. (PMID: 16087714)
Mult Scler. 2018 Jan;24(1):75-79. (PMID: 29307290)
Mult Scler. 2019 Oct;25(11):1427-1433. (PMID: 30907249)
Nat Rev Immunol. 2018 Jan;18(1):35-45. (PMID: 28787399)
Entry Date(s):: Date Created: 20200915 Date Completed: 20201105 Latest Revision: 20210314
Update Code:: 20240105
PubMed Central ID:: PMC7533650
DOI:: 10.1073/pnas.2016711117
PMID:: 32929024
: Czasopismo naukowe

Competing Interests: Competing interest statement: P.V. holds stock and has received consultancy payments from Accure Therapeutics SL, Spiral Therapeutics Inc., Health Engineering SL, Attune Neurosciences Inc., QMenta Inc., C Light Inc., and NeuroPrex Inc. S.S.Z. served on data safety monitoring boards of Opexa, BioMS, Teva, and Eli Lilly; is a member of the clinical advisory board of the Myelin Repair Foundation; received speaker honoraria from Biogen and Teva; is a deputy editor of Neurology: Neuroimmunology and Neuroinflammation; consulted for Biogen, Teva, EMD Serono, Genzyme, Novartis, and Roche; serves on the speaker's bureau of Advanced Health Media and Biogen; and received research support from Biogen, Teva, the NIH, the National Multiple Sclerosis Society, the Weill Institute, and Alexander M. and June L. Maisin Foundation.

Comment on: Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21546-21556. (PMID: 32817525)

Informacja